Ketorolac Tromethamine Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Ketorolac Tromethamine Injection (injection) from Alembic Pharmaceuticals with status Current. The shortage was first posted on 03/23/2018.
Shortage Details
- Status
- Current
- Company
- Alembic Pharmaceuticals
- Package NDC
- 62332-599-25
- Dosage Form
- Injection
- Presentation
- Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 62332-599-25)
- Initial Posting
- 03/23/2018
- Revised Date